154 related articles for article (PubMed ID: 18717997)
1. Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study.
Ting G; Schneeweiss S; Scranton R; Katz JN; Weinblatt ME; Young M; Avorn J; Solomon DH
Arthritis Res Ther; 2008; 10(4):R95. PubMed ID: 18717997
[TBL] [Abstract][Full Text] [Related]
2. Severity indices in rheumatoid arthritis: A systematic review.
Toledano E; García de Yébenes MJ; González-Álvaro I; Carmona L
Reumatol Clin (Engl Ed); 2019; 15(3):146-151. PubMed ID: 28807652
[TBL] [Abstract][Full Text] [Related]
3. Performance of a rheumatoid arthritis records-based index of severity.
Ting G; Schneeweiss S; Katz JN; Weinblatt ME; Cabral D; Scranton RE; Solomon DH
J Rheumatol; 2005 Sep; 32(9):1679-87. PubMed ID: 16142860
[TBL] [Abstract][Full Text] [Related]
4. Rheumatoid arthritis disease severity indices in administrative databases: a systematic review.
Vinet E; Kuriya B; Widdifield J; Bernatsky S
J Rheumatol; 2011 Nov; 38(11):2318-25. PubMed ID: 21921094
[TBL] [Abstract][Full Text] [Related]
5. The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28.
Sato M; Schneeweiss S; Scranton R; Katz JN; Weinblatt ME; Avorn J; Ting G; Shadick NA; Solomon DH
Arthritis Res Ther; 2006; 8(3):R57. PubMed ID: 16542499
[TBL] [Abstract][Full Text] [Related]
6. Derivation of severity index for rheumatoid arthritis and its association with healthcare outcomes.
Baser O; Du J; Xie L; Wang H; Dysinger AH; Wang L
J Med Econ; 2012; 15(5):918-24. PubMed ID: 22533525
[TBL] [Abstract][Full Text] [Related]
7. The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease.
Myasoedova E; Chandran A; Ilhan B; Major BT; Michet CJ; Matteson EL; Crowson CS
Ann Rheum Dis; 2016 Mar; 75(3):560-5. PubMed ID: 25637001
[TBL] [Abstract][Full Text] [Related]
8. An external validation study reporting poor correlation between the claims-based index for rheumatoid arthritis severity and the disease activity score.
Desai RJ; Solomon DH; Weinblatt ME; Shadick N; Kim SC
Arthritis Res Ther; 2015 Apr; 17(1):83. PubMed ID: 25880932
[TBL] [Abstract][Full Text] [Related]
9. Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis.
Curtis JR; Baddley JW; Yang S; Patkar N; Chen L; Delzell E; Mikuls TR; Saag KG; Singh J; Safford M; Cannon GW
Arthritis Res Ther; 2011; 13(5):R155. PubMed ID: 21933396
[TBL] [Abstract][Full Text] [Related]
10. Inferring disease severity in rheumatoid arthritis using predictive modeling in administrative claims databases.
Chandran U; Reps J; Stang PE; Ryan PB
PLoS One; 2019; 14(12):e0226255. PubMed ID: 31851711
[TBL] [Abstract][Full Text] [Related]
11. Models solely using claims-based administrative data are poor predictors of rheumatoid arthritis disease activity.
Sauer BC; Teng CC; Accortt NA; Burningham Z; Collier D; Trivedi M; Cannon GW
Arthritis Res Ther; 2017 May; 19(1):86. PubMed ID: 28482933
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data.
Chung CP; Rohan P; Krishnaswami S; McPheeters ML
Vaccine; 2013 Dec; 31 Suppl 10():K41-61. PubMed ID: 24331074
[TBL] [Abstract][Full Text] [Related]
13. Changes in Healthcare Utilization After Etanercept Initiation in Patients with Rheumatoid Arthritis: A Retrospective Claims Analysis.
Accortt NA; Schenfeld J; Chang E; Papoyan E; Broder MS
Adv Ther; 2017 Sep; 34(9):2093-2103. PubMed ID: 28770517
[TBL] [Abstract][Full Text] [Related]
14. Validation of the French version of the arthritis impact measurement scales 2 and comparison with the french version of the Nottingham Health Profile. "Quality of Life in Rheumatology" Task Force.
Pouchot J; Guillemin F; Coste J; Brégeon C; Sany J
Rev Rhum Engl Ed; 1996 Jun; 63(6):389-404. PubMed ID: 8817749
[TBL] [Abstract][Full Text] [Related]
15. Identification of rheumatoid arthritis patients using an administrative database: a Veterans Affairs study.
Ng B; Aslam F; Petersen NJ; Yu HJ; Suarez-Almazor ME
Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1490-6. PubMed ID: 22623324
[TBL] [Abstract][Full Text] [Related]
16. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
Shadick NA; Gerlanc NM; Frits ML; Stolshek BS; Brady BL; Iannaccone C; Collier D; Cui J; Mutebi A; Weinblatt ME
Clin Rheumatol; 2019 Nov; 38(11):3081-3092. PubMed ID: 31353421
[TBL] [Abstract][Full Text] [Related]
17. Refining a Claims-based Algorithm to Estimate Biologic Medication Effectiveness and Cost per Effectively Treated Patient with Rheumatoid Arthritis.
Popp RA; Rascati K; Davis M; Patel U
Pharmacotherapy; 2018 Feb; 38(2):172-180. PubMed ID: 29197108
[TBL] [Abstract][Full Text] [Related]
18. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories.
Pincus T; Swearingen CJ; Bergman M; Yazici Y
J Rheumatol; 2008 Nov; 35(11):2136-47. PubMed ID: 18793006
[TBL] [Abstract][Full Text] [Related]
19. Use of administrative claims data for comparative effectiveness research of rheumatoid arthritis treatments.
Kim SY; Solomon DH
Arthritis Res Ther; 2011; 13(5):129. PubMed ID: 21996148
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a patient-based disease activity score in rheumatoid arthritis that can be used in clinical trials and routine practice.
Choy EH; Khoshaba B; Cooper D; MacGregor A; Scott DL
Arthritis Rheum; 2008 Feb; 59(2):192-9. PubMed ID: 18240256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
